Professor Douglas A. Melton (Xander University Professor at Harvard University, Co-chair of the Harvard University Department of Stem Cell and Regenerative Biology) was awarded the 2016 Ogawa-Yamanaka Stem Cell Prize and its $150,000 prize by the Gladstone Institutes. Professor Melton was recognized for his research on using stem cells for developing insulin-producing beta cells for the treatment of diabetes.
Professor Michael V. Sefton (Michael E. Charles Professor of Chemical Engineering, University of Toronto) received the Lifetime Achievement Award from the Tissue Engineering and Regenerative Medicine International Society (TERMIS) for the year 2016. Professor Sefton was recognized for his lifelong commitment and achievements to the field. Prof. Sefton was one of the first to use scaffolds with cells, effectively pioneering the modern day field of tissue engineering.
Professor Ali Khademhosseini (Professor at Harvard Medical School) was honored with the Senior Scientist Award from the TERMIS for his significant contributions in the field of tissue engineering and regenerative medicine. Professor Khademhosseini has recognized for developing numerous innovative materials and technologies for controlling composition, structure, and function of engineered tissues. 
Views: Recent Advances in the Field

Advancements in Industry
AiVita Biomedical, an Irvine, CA based company developing stem cell technologies, received an R01 grant from the National Eye Institute (NEI), National Institute of Health (NIH). AiVita will manufacture stem cell-derived transplantable retinas to cure vision loss. Sue and Bill Gross Stem Cell Research Center at University of California Irvine will collaborate with AitVita for testing safety and efficacy of the product in retinal degeneration models.
Poietis, a Pessac, France based biotechnology company creating human tissues for regenerative medical purposes, made partnership with L'Oreal to bioprint functional hair follicles, the skin organ that grows hair. L'Oreal has dedicated itself to tissue engineering for the last 30 years and has extensive experience with hair biology. During this multi-annual research partnership, Poietis will use its unique laser-assisted bioprinting technology with extremely high resolution for hair engineering.
Advancements in Academia
Scientists at Massachusetts Institute of Technology have developed a wearable second skin by utilizing skin-adherent polysiloxane-based crosslinkable polymer materials with tunable elasticity and tensile strength. This wearable crosslinked polymer layer (XPL) looked similar with healthy normal skin and exhibited enhanced skin barrier function. In a human pilot study, a tensile modulus of a prototype XPL matched well with normal skin, withstanding elongation more than 250%. The XPL second skin platform can be potentially applied for wound dressing. This research was published in Nature Materials.
Scientists at Seoul National University have developed a skin-mounted, graphene-based electrochemical patch for monitoring and treating diabetes. This wearable, stretchable patch consists of sensors that can monitor glucose level in sweat and thermoresponsive polymeric microneedles that can deliver drugs transcutaneously. When glucose concentration is high, embedded heaters are triggered to dissolve biodegradable polymeric microneedles to release drugs. This diabetes patch study was published in Nature Nanotechnology.
Philanthropic Support
Facebook co-founder Mark Zuckerberg and Priscila Chan announced a $3 billion plan to bring teams of scientists and engineers with an ambitious goal of preventing and curing all diseases before the end of this century. Bill Gates, co-founder of Microsoft Corp. also supported this plan. As an initiative step, a $600 million will be funded over 10 years to establish a new research center, the Chan Zuckerberg Biohub, in partnership with Stanford University, University of California, Berkeley, and University of California at San Francisco (UCSF). Professor Joseph DeRisi (Professor and Chair of the Department of Biochemistry and Biophysics at the UCSF) and Stephen Quake (Professor of bioengineering and applied physics at Stanford University) will co-lead the Biohub.
